Table of Contents
Understanding Healthcare Provider Bias and Its Critical Role in Diabetes Treatment Equity
Diabetes mellitus represents one of the most significant public health challenges facing the United States today, affecting more than 38 million adults nationwide. The economic burden is staggering, with health care costs and lost work and wages totaling $413 billion a year, making diabetes the most expensive chronic condition in America. Yet beyond these sobering statistics lies an even more troubling reality: not all patients with diabetes receive equal care or experience comparable health outcomes. Healthcare provider bias—both conscious and unconscious—plays a substantial role in perpetuating these disparities, creating barriers to optimal treatment that disproportionately affect marginalized communities.
The intersection of healthcare provider bias and diabetes treatment represents a critical area of concern for healthcare systems, policymakers, and communities working to achieve health equity. Understanding how provider attitudes and beliefs influence clinical decision-making is essential for developing effective interventions that can improve outcomes for all patients, regardless of their race, ethnicity, socioeconomic status, or other demographic characteristics.
The Scope of Diabetes Disparities in America
Before examining the role of provider bias, it is important to understand the magnitude of diabetes disparities across different populations. Differences in the occurrence of diabetes and its related complications depend on factors such as income, geographic location, education level, race, and ethnicity. The data reveals stark inequalities that cannot be explained by biological factors alone.
Racial and Ethnic Disparities in Diabetes Prevalence
Minority populations, including African Americans, Hispanics, and Native Americans, consistently exhibit higher rates of diabetes than their Caucasian counterparts. The differences are substantial and persistent. While diabetes affects approximately 7.5% of non-Hispanic White adults, the prevalence rises to 9.2% among non-Hispanic Asians, 11.7% among non-Hispanic Blacks, 12.5% among Hispanics, and a striking 14.7% among American Indians and Alaska Natives.
These disparities extend far beyond prevalence rates. Black Americans are twice as likely to succumb to diabetes-related mortality compared to Whites, highlighting how inequities in care translate directly into life-and-death outcomes. The burden of diabetes-related complications—including cardiovascular disease, kidney failure, vision loss, and amputations—also falls disproportionately on minority communities.
Beyond Prevalence: Disparities in Access and Quality of Care
Beyond prevalence, disparities extend to access to healthcare resources, diabetes education, and preventive measures. Patients from marginalized communities often face multiple barriers to receiving optimal diabetes care, including limited access to endocrinologists and diabetes specialists, reduced availability of diabetes self-management education programs, fewer opportunities to utilize advanced diabetes technologies such as continuous glucose monitors and insulin pumps, and inadequate access to affordable medications and supplies.
These access barriers are compounded by social determinants of health that make diabetes management more challenging. Food insecurity, housing instability, transportation difficulties, and limited health literacy all contribute to poorer diabetes outcomes. However, even when controlling for these social factors, disparities in treatment and outcomes persist—pointing to the role of provider bias in clinical decision-making.
Defining Healthcare Provider Bias: Implicit and Explicit Forms
Healthcare provider bias encompasses the attitudes, beliefs, and stereotypes that influence how clinicians perceive, interact with, and make treatment decisions for their patients. These biases can manifest in both conscious and unconscious forms, each with distinct characteristics and impacts on patient care.
Implicit Bias: The Unconscious Influence on Clinical Decisions
Implicit bias, also called unconscious bias, refers to associations outside of conscious awareness that adversely affect one’s perception of a person or group. These automatic mental associations develop over time through exposure to cultural messages, media representations, and personal experiences. Importantly, individuals can hold implicit biases that contradict their explicitly stated values and beliefs.
In the context of diabetes care, implicit bias can influence numerous aspects of the patient-provider interaction. In the sphere of health care, racially and ethnically minoritized patients are often viewed as less intelligent, less able to comprehend and adhere to treatment recommendations, and less interested in their health than nonminoritized patients. These unconscious assumptions can lead providers to offer less intensive treatment options, provide less detailed education, or make assumptions about patient capabilities without adequate assessment.
Studies assessing implicit bias using the Implicit Association Test (IAT) have demonstrated that these biases are associated with disparities in empathy, treatment recommendations, and expectations of therapy adherence. The IAT measures the strength of automatic associations between concepts, revealing biases that individuals may not consciously recognize or acknowledge.
Explicit Bias: Conscious Beliefs That Shape Treatment
While implicit bias operates below the level of conscious awareness, explicit bias involves conscious beliefs and attitudes that individuals are aware of and may openly express. In healthcare settings, explicit bias is less common than implicit bias, as most healthcare providers consciously endorse egalitarian values and strive to provide equitable care. However, explicit biases can still influence clinical practice, particularly when they are reinforced by institutional norms or systemic factors.
Explicit biases may manifest as overt discrimination, differential treatment based on patient characteristics, or conscious stereotyping. These biases are generally easier to identify and address than implicit biases, as they involve conscious thought processes that can be directly challenged and changed through education and accountability measures.
Weight-Based Bias in Diabetes Care
The presence of obesity is another characteristic that seems to draw implicit bias in health care, particularly in diabetes care. Physicians have been found to show a preference for patients who are thin, which may negatively affect the care experiences of individuals with overweight or obesity. This form of bias is particularly relevant in diabetes care, as type 2 diabetes is strongly associated with obesity, and many patients with diabetes struggle with weight management.
Weight-based bias can lead to stigmatization, reduced empathy, and assumptions that patients are personally responsible for their condition due to poor lifestyle choices. This can create a judgmental atmosphere that discourages patients from seeking care, reduces treatment adherence, and damages the therapeutic relationship between patients and providers.
How Provider Bias Manifests in Diabetes Treatment
The impact of healthcare provider bias on diabetes treatment is multifaceted, affecting everything from initial diagnosis and treatment planning to ongoing management and access to advanced technologies. Understanding these specific manifestations is crucial for developing targeted interventions.
Disparities in Medication Prescribing Patterns
One of the most well-documented manifestations of provider bias in diabetes care involves differences in medication prescribing patterns across racial and ethnic groups. Less intensive lifestyle modification and pharmacological approaches in racially and ethnically minoritized patients may be related to implicit biases on the part of diabetes care professionals. This can result in minority patients receiving older, less effective medications or being less likely to have their treatment intensified when glycemic control is inadequate.
Research has documented that minority patients are less likely to be prescribed newer classes of diabetes medications, such as GLP-1 receptor agonists and SGLT2 inhibitors, which offer cardiovascular and renal protective benefits beyond glucose control. They are also less likely to receive insulin therapy when clinically indicated, potentially due to provider assumptions about patient ability or willingness to manage complex insulin regimens.
Inequitable Access to Diabetes Technology
The advent of diabetes technologies—including continuous glucose monitors (CGMs), insulin pumps, and automated insulin delivery systems—has revolutionized diabetes management. However, access to these life-changing technologies is far from equitable. Barriers to technology adoption included implicit bias/institutional racism, social determinants of health, cost, access, geography, education, culture, individuals’ and HCPs’ preference, and health literacy and that these barriers resulted in significant care disparities.
The lowest technology utilization rates were among Black patients, followed by Hispanics. This sequence in utilization rates remains even after adjusting for age, sex, study site, insurance type, education level, and neighborhood poverty level. This persistence of disparities even after controlling for socioeconomic factors strongly suggests that provider bias plays a role in technology recommendations.
Provider implicit bias can influence technology recommendations in several ways. Clinicians may make assumptions about which patients will be able to successfully use complex technologies, which patients will be compliant with device requirements, or which patients and families will be interested in technology-based management. These assumptions, often made unconsciously, can result in providers failing to offer technology options to minority patients or presenting them in a less enthusiastic or supportive manner.
Differences in Patient Education and Self-Management Support
Effective diabetes management requires substantial patient education and ongoing self-management support. However, the quality and quantity of education provided can vary significantly based on provider perceptions and biases. When providers unconsciously view certain patients as less capable of understanding complex medical information or less motivated to engage in self-care, they may provide less detailed explanations, use more simplified language, or spend less time on education.
This creates a self-fulfilling prophecy: patients who receive less comprehensive education and support are less equipped to manage their diabetes effectively, which may reinforce provider biases about their capabilities or motivation. Additionally, reduced access to formal diabetes self-management education programs—which are often less available in underserved communities—compounds these disparities.
Variations in Monitoring and Follow-Up Care
Optimal diabetes management requires regular monitoring of blood glucose levels, periodic assessment of hemoglobin A1c, and screening for diabetes-related complications. Provider bias can influence the frequency and thoroughness of this monitoring. Patients from marginalized groups may receive less frequent follow-up appointments, less comprehensive complication screening, or less aggressive treatment adjustments when targets are not met.
These differences in monitoring intensity can have serious consequences, as delayed detection of complications or inadequate treatment intensification can lead to preventable morbidity and mortality. The cumulative effect of these small differences in care over time can result in substantial disparities in long-term outcomes.
Communication Barriers and Patient-Provider Relationships
After two decades of research studying unconscious bias, studies have revealed that providers with higher levels of implicit bias toward Black, Hispanic, or American Indian people demonstrate poorer patient-provider communication with those groups. Poor communication can manifest as shorter visit times, less patient-centered dialogue, reduced empathy, and decreased shared decision-making.
The quality of the patient-provider relationship is a critical determinant of treatment adherence, patient satisfaction, and health outcomes. When patients perceive bias or discrimination in their healthcare interactions, they may be less likely to follow treatment recommendations, less likely to return for follow-up care, and more likely to experience diabetes distress and reduced quality of life.
The Broader Context: Systemic and Structural Factors
While individual provider bias is an important contributor to diabetes treatment disparities, it operates within a broader context of systemic and structural factors that perpetuate inequity. Outside of SDOH, there are several contributors to inequities, including bias, institutional practices, and systemic factors. Understanding this context is essential for developing comprehensive solutions.
Institutional Racism and Healthcare Systems
Institutional racism refers to policies, practices, and procedures within organizations that result in differential treatment or outcomes for different racial or ethnic groups, regardless of individual intent. In healthcare systems, institutional racism can manifest through insurance policies that limit access to certain treatments or technologies, clinic locations and hours that are inconvenient for working patients, lack of interpreter services for non-English speakers, and absence of culturally tailored care approaches.
These institutional factors interact with individual provider bias to create compounding barriers to equitable care. Even well-intentioned providers working within biased systems may inadvertently perpetuate disparities through their adherence to institutional norms and practices.
Social Determinants of Health
To tackle these disparities, it may be essential to have a clear understanding of the social determinants of health (SDOH) that lead to them. Social determinants of health encompass the conditions in which people are born, grow, live, work, and age, including factors such as economic stability, education access and quality, healthcare access and quality, neighborhood and built environment, and social and community context.
For individuals with diabetes, SDOH can profoundly impact disease management and outcomes. Food insecurity makes it difficult to follow dietary recommendations, housing instability creates barriers to medication storage and regular routines, lack of transportation limits access to healthcare appointments and pharmacies, and financial constraints force difficult choices between medications and other necessities.
The CMS Framework for Health Equity prioritizes collection, reporting, and analysis of standardized individual-level demographic and SDOH data. Quality measures assessing SDOH screening and intervention have been introduced by the National Committee for Quality Assurance (focused on food, housing, and transportation insecurity) and CMS (focused on food, housing, and transportation insecurity, utility difficulties, and interpersonal safety). These initiatives recognize that addressing health disparities requires attention to the social context of patients’ lives.
Geographic Disparities and Rural Healthcare Access
Geographical variations in the burden of diabetes-related complications are multifactorial, influenced by differences in socioeconomic development, healthcare resources, environmental exposures, and traditional and cultural practices, along with varying ethnic compositions. Rural communities often face particular challenges in accessing specialized diabetes care, with fewer endocrinologists and diabetes educators, limited availability of diabetes technologies, greater distances to healthcare facilities, and reduced access to healthy food options.
These geographic disparities intersect with racial and ethnic disparities, as minority populations are disproportionately represented in underserved rural and urban areas. The combination of geographic isolation and provider bias can create particularly severe barriers to optimal diabetes care.
The Evidence on Implicit Bias Training: Promise and Limitations
Given the significant role of provider bias in perpetuating diabetes treatment disparities, healthcare organizations have increasingly turned to implicit bias training as an intervention strategy. Understanding what the evidence shows about the effectiveness of these trainings is crucial for developing realistic expectations and evidence-based approaches.
Positive Impacts on Knowledge, Attitudes, and Awareness
Ninety-six percent of the 56 selected studies reported an overall positive association of the intervention on trainees’ knowledge, awareness, and skills. This represents a substantial body of evidence suggesting that implicit bias training can effectively increase provider awareness of bias and its potential impacts on patient care.
Positive outcomes included increases in knowledge, skills, and attitudes around implicit bias; increased confidence in recognizing personal implicit biases; increased awareness of personal biases; and improved ability to identify strategies for identifying and managing one’s potential biases regarding patients. These findings suggest that training can successfully raise consciousness about bias and equip providers with conceptual tools for addressing it.
Online courses demonstrated effectiveness in enhancing awareness across various provider groups, regardless of baseline bias levels. Workshops that utilized tools like the Implicit Association Test (IAT) also showed notable improvements in bias awareness among medical students, with retention lasting up to one year. This suggests that various training formats can be effective and that gains in awareness can persist over time.
The Gap Between Awareness and Behavior Change
While the evidence for improved knowledge and awareness is encouraging, the link between these outcomes and actual changes in provider behavior or patient outcomes remains less clear. While the goal of implicit bias training is ultimately to improve provider behaviors and/or patient outcomes, most trainings focused on changing attitudes or beliefs alone. This represents a significant gap in the evidence base.
Our search did not find any studies specifically addressing HCW implicit bias training and education effects on patient health and safety outcomes. This absence of evidence on patient-level outcomes is a critical limitation, as the ultimate goal of bias training is not simply to increase awareness but to improve the quality and equity of patient care.
None of the interventions reviewed achieved sustained reduction of implicit bias in healthcare professionals. This finding highlights a fundamental challenge: even when training successfully raises awareness, it may not produce lasting changes in the automatic associations that constitute implicit bias.
Methodological Limitations of Current Research
Few studies used validated measures and rigorous empirical approaches such as randomized designs to test efficacy. The methodological quality of research on implicit bias training varies considerably, with many studies lacking control groups, using non-validated outcome measures, or failing to assess long-term retention of training effects.
Most training is delivered at a single time point, lasting less than 6 hours on average. While this likely reflects the constraints imposed by the current health care system and medical education, these findings suggest that attendees were unlikely to have enough opportunities to practice newly learned strategies to mitigate their implicit bias. This brief, one-time training approach may be insufficient to produce meaningful behavior change.
The Need for Comprehensive Approaches
It is premature to answer whether implicit bias training works. There is little scientific evidence to support that implicit bias training improves the quality of patient care. This sobering conclusion does not mean that efforts to address provider bias should be abandoned, but rather that training alone is insufficient.
A single diversity training program is not enough to reduce implicit bias in the workplace. Effective approaches require ongoing education, institutional commitment, systemic changes to policies and practices, and accountability mechanisms that extend beyond individual awareness.
Evidence-Based Strategies for Reducing Bias in Diabetes Care
While implicit bias training alone may be insufficient, a comprehensive, multi-faceted approach that combines education with systemic interventions shows greater promise for reducing bias and improving equity in diabetes care. The following strategies represent evidence-based best practices that healthcare organizations can implement.
Implementing Standardized Treatment Protocols
One of the most effective strategies for reducing the impact of provider bias is to minimize opportunities for subjective decision-making through the use of standardized treatment protocols and clinical decision support tools. When treatment decisions are guided by objective criteria and evidence-based algorithms, there is less room for unconscious biases to influence care.
Standardized protocols can specify criteria for treatment intensification, guidelines for when to offer diabetes technologies, algorithms for complication screening, and pathways for referral to specialists. By making these decisions more algorithmic and less dependent on individual provider judgment, healthcare systems can reduce disparities in care delivery.
Electronic health record systems can incorporate clinical decision support tools that prompt providers to follow standardized protocols, flag patients who are due for screening or treatment intensification, and provide evidence-based recommendations at the point of care. These technological supports can help ensure that all patients receive guideline-concordant care regardless of their demographic characteristics.
Enhancing Cultural Competence and Humility
Cultural competence training goes beyond implicit bias awareness to provide providers with specific knowledge and skills for working effectively with diverse patient populations. This includes understanding how cultural beliefs and practices influence health behaviors, recognizing the impact of historical trauma and discrimination on health and healthcare engagement, developing communication strategies that bridge cultural differences, and adapting care approaches to align with patients’ cultural values and preferences.
Cultural humility extends this concept by emphasizing ongoing self-reflection, recognition of power imbalances in the patient-provider relationship, and commitment to lifelong learning about diverse cultures and experiences. Rather than viewing cultural competence as a finite set of knowledge to be acquired, cultural humility recognizes that understanding others is an ongoing process that requires openness, curiosity, and willingness to learn from patients.
Promoting Patient-Centered Communication and Shared Decision-Making
Patient-centered communication involves actively listening to patients’ concerns, eliciting their perspectives and preferences, providing information in accessible language, and engaging in collaborative decision-making. This approach can help counteract the effects of bias by ensuring that treatment decisions are based on individual patient needs and preferences rather than provider assumptions.
Shared decision-making is particularly important for decisions about diabetes technologies and treatment intensification. Rather than making assumptions about which patients would benefit from or be interested in advanced technologies, providers should present options to all eligible patients and engage in collaborative discussions about the benefits, risks, and practical considerations of different approaches.
Training in motivational interviewing and other patient-centered communication techniques can help providers develop skills for engaging patients in meaningful dialogue about their diabetes management. These approaches emphasize partnership, acceptance, compassion, and evocation of the patient’s own motivations and resources.
Addressing Social Determinants of Health
Reducing diabetes treatment disparities requires addressing the social determinants of health that create barriers to optimal care. Healthcare organizations can implement systematic screening for social needs, establish partnerships with community organizations to address identified needs, provide resources and referrals for food assistance, housing support, and transportation, and advocate for policies that address social inequities.
Some healthcare systems have developed innovative programs that integrate social services into diabetes care, such as food pharmacies that provide healthy food to patients with food insecurity, medical-legal partnerships that help patients address housing and benefits issues, and community health worker programs that provide culturally tailored support and navigation assistance.
Increasing Workforce Diversity
Increasing diversity within the healthcare workforce can help reduce disparities by providing patients with providers who share their cultural background and lived experiences, bringing diverse perspectives to clinical decision-making and policy development, and challenging institutional norms and practices that perpetuate inequity. Research has shown that racial and ethnic concordance between patients and providers is associated with improved communication, greater patient satisfaction, and better health outcomes.
Healthcare organizations can promote workforce diversity through targeted recruitment and retention efforts, mentorship and support programs for underrepresented minorities in healthcare, and creation of inclusive organizational cultures that value diversity and address discrimination.
Implementing Data-Driven Quality Improvement
Regular monitoring and analysis of quality metrics stratified by race, ethnicity, and other demographic factors can help identify disparities and track progress toward equity. Healthcare organizations should collect and analyze data on diabetes process measures (such as A1c testing, eye exams, and foot exams), outcome measures (such as A1c control and complication rates), and treatment patterns (such as medication prescribing and technology utilization).
When disparities are identified, organizations can implement targeted quality improvement initiatives to address them. This might include provider feedback on their individual performance metrics stratified by patient demographics, focused interventions to improve care for populations experiencing disparities, and accountability mechanisms that tie performance on equity metrics to organizational goals and incentives.
Creating Accountability Structures
Sustainable change requires accountability structures that extend beyond individual awareness and good intentions. Healthcare organizations can establish equity as an explicit organizational priority with dedicated leadership and resources, incorporate equity metrics into performance evaluations and quality reporting, create mechanisms for patients to report experiences of bias or discrimination, and implement policies that address identified inequities in care delivery.
Leadership commitment is essential for creating organizational cultures that prioritize equity. When leaders consistently communicate the importance of equitable care, allocate resources to equity initiatives, and hold individuals and teams accountable for equity outcomes, it signals that addressing disparities is a core organizational value rather than a peripheral concern.
The Role of Policy and System-Level Interventions
While healthcare organizations can implement many strategies to reduce bias and improve equity, broader policy and system-level interventions are also necessary to address the structural factors that perpetuate disparities in diabetes care.
Expanding Insurance Coverage and Reducing Cost Barriers
The Inflation Reduction Act of 2022 capped out-of-pocket payments for insulin at $35 per insulin per month for all Medicare beneficiaries. Over the past 5 years, 25 states and the District of Columbia have capped out-of-pocket expenditures for insulin in select state-regulated commercial health plans. Between 2023 and 2024, three major insulin manufacturers similarly lowered the price of insulin to $35 per month in select circumstances. These policy changes represent important progress in addressing cost barriers to diabetes care.
However, gaps remain in coverage for other diabetes medications, technologies, and supplies. Continued policy advocacy is needed to ensure that all individuals with diabetes have access to affordable, comprehensive care regardless of their insurance status or ability to pay. This includes expanding Medicaid in states that have not yet done so, improving coverage for diabetes technologies and newer medication classes, and addressing cost-sharing requirements that create barriers to care.
Strengthening Primary Care and Community-Based Services
Most diabetes care is delivered in primary care settings, yet primary care is chronically underfunded and understaffed in many communities. Strengthening primary care infrastructure through increased reimbursement for primary care services, support for team-based care models that include nurses, pharmacists, and diabetes educators, and investment in community health centers serving underserved populations can improve access to high-quality diabetes care.
Community-based programs that provide diabetes self-management education, support groups, and lifestyle interventions can complement clinical care and address social and cultural factors that influence diabetes management. These programs are particularly effective when they are culturally tailored and delivered by community health workers or peer educators who share the cultural background of participants.
Leveraging Telehealth to Improve Access
The expansion of telehealth during the COVID-19 pandemic demonstrated its potential to improve access to diabetes care, particularly for patients in rural areas or those facing transportation barriers. Continued support for telehealth through sustained reimbursement policies, investment in broadband infrastructure to ensure connectivity, and development of culturally appropriate telehealth programs can help reduce geographic and access-related disparities.
However, it is important to recognize that telehealth is not a panacea and may create new disparities if not implemented thoughtfully. Digital literacy, access to technology, and language barriers can limit telehealth utilization among some populations. Hybrid models that combine in-person and virtual care may be most effective for ensuring equitable access.
Investing in Research on Health Disparities
Continued research is needed to better understand the mechanisms underlying diabetes disparities and to develop and test interventions to address them. This includes research on the prevalence and impact of provider bias in diabetes care, effectiveness of different approaches to bias reduction, optimal strategies for addressing social determinants of health, and interventions to improve diabetes outcomes in specific populations experiencing disparities.
Research funding should prioritize community-engaged approaches that involve affected communities in all stages of the research process, from question formulation to dissemination of findings. This ensures that research addresses questions that are meaningful to communities and that findings are translated into actionable interventions.
Patient Perspectives and Experiences of Bias
Understanding how patients experience bias in healthcare settings is essential for developing effective interventions. About 5.7 percent of adults reported experiencing unfair treatment in health care settings, with much higher rates reported by patients who are Black, Hispanic, or disabled. These experiences have profound impacts on patients’ willingness to engage with the healthcare system and their health outcomes.
The Impact of Perceived Discrimination on Diabetes Outcomes
When patients perceive discrimination or bias in their healthcare interactions, it can lead to reduced trust in providers and the healthcare system, decreased treatment adherence, avoidance of healthcare services, increased diabetes distress and psychological burden, and poorer glycemic control and health outcomes. Diabetes stigma is negatively associated with both diabetes distress and glycemic control, highlighting the direct link between experiences of bias and health outcomes.
Diabetes distress—the emotional burden of living with diabetes and managing its demands—is already high among people with diabetes. When this is compounded by experiences of discrimination or bias in healthcare settings, it can become overwhelming and lead to disengagement from care. Addressing provider bias is therefore not only a matter of equity but also a clinical imperative for improving diabetes outcomes.
Centering Patient Voices in Quality Improvement
Efforts to reduce bias and improve equity must center the voices and experiences of patients who have been affected by disparities. This can be accomplished through patient advisory councils that inform organizational policies and practices, patient experience surveys that assess perceptions of bias and discrimination, qualitative research that explores patients’ experiences in depth, and community forums that provide opportunities for dialogue between patients and healthcare leaders.
When patients are meaningfully involved in designing and implementing interventions to address bias, the resulting programs are more likely to be effective and responsive to community needs. This participatory approach also helps build trust between healthcare organizations and the communities they serve.
Moving Forward: A Call to Action for Healthcare Providers and Systems
Addressing healthcare provider bias and its impact on diabetes treatment equity requires sustained commitment and action at multiple levels—from individual providers to healthcare organizations to policy makers. While the challenges are significant, there are concrete steps that can be taken to move toward more equitable care.
For Individual Healthcare Providers
Individual providers can take several steps to recognize and address their own biases. This includes engaging in ongoing self-reflection about personal biases and assumptions, participating in implicit bias training and cultural competence education, seeking feedback from patients and colleagues about communication and care delivery, using standardized protocols and decision support tools to minimize subjective decision-making, and practicing patient-centered communication and shared decision-making with all patients.
Providers should also commit to offering all evidence-based treatment options to all eligible patients, regardless of assumptions about patient interest or capability. This means presenting diabetes technologies, newer medication classes, and intensive management strategies to all patients who might benefit, and engaging in collaborative discussions about the best approach for each individual.
For Healthcare Organizations
Healthcare organizations must make equity a strategic priority supported by dedicated resources and leadership commitment. This includes collecting and analyzing data on disparities in diabetes care and outcomes, implementing comprehensive interventions that address bias at individual, interpersonal, and systemic levels, establishing accountability mechanisms for equity outcomes, investing in workforce diversity and cultural competence, and partnering with community organizations to address social determinants of health.
Organizations should move beyond one-time training sessions to create ongoing learning opportunities and embed equity principles throughout organizational policies, practices, and culture. This requires sustained effort and willingness to examine and change practices that may have been in place for years but that perpetuate inequity.
For Policy Makers and Health System Leaders
Policy makers and health system leaders have a critical role in creating the conditions for equitable diabetes care through expanding insurance coverage and reducing cost barriers to medications and technologies, investing in primary care and community-based services in underserved areas, supporting research on health disparities and interventions to address them, requiring collection and reporting of equity metrics, and addressing social determinants of health through cross-sector collaboration.
Payment and reimbursement models should incentivize equitable care and reward organizations that successfully reduce disparities. Quality metrics should include equity measures, and organizations should be held accountable for achieving equitable outcomes across all patient populations.
Conclusion: The Path Toward Diabetes Treatment Equity
Healthcare provider bias represents a significant but addressable contributor to disparities in diabetes treatment and outcomes. Despite global efforts to address health inequities, unconscious bias among healthcare providers may exacerbate inequalities in prescribing practices, diabetes education and the provision of other diabetes support. Recognizing this reality is the first step toward meaningful change.
The evidence is clear that implicit bias training alone, while valuable for raising awareness, is insufficient to produce sustained changes in provider behavior or patient outcomes. What is needed is a comprehensive, multi-faceted approach that combines education with systemic interventions, standardized protocols, accountability mechanisms, and attention to the broader social and structural factors that perpetuate inequity.
Achieving diabetes treatment equity will require sustained commitment from all stakeholders in the healthcare system. Providers must engage in ongoing self-reflection and commit to patient-centered, culturally responsive care. Healthcare organizations must make equity a strategic priority and implement comprehensive interventions to address bias at all levels. Policy makers must create supportive policies and invest in the infrastructure needed to deliver equitable care. And patients and communities must be meaningfully involved in designing and implementing solutions.
The stakes are high. Diabetes is a leading cause of morbidity and mortality in the United States, and the burden falls disproportionately on communities that have historically experienced discrimination and marginalization. Every day that disparities persist, individuals suffer preventable complications, families experience unnecessary hardship, and communities bear an inequitable burden of disease.
But there is also reason for hope. We have the knowledge, tools, and resources to deliver high-quality diabetes care to all patients. What is needed is the will to confront uncomfortable truths about bias and inequity, the commitment to implement evidence-based solutions, and the persistence to sustain these efforts over time. By working together across disciplines, sectors, and communities, we can move toward a future where all individuals with diabetes receive the care they need and deserve, regardless of their race, ethnicity, socioeconomic status, or other demographic characteristics.
The journey toward diabetes treatment equity is ongoing, but each step forward brings us closer to a healthcare system that truly serves all patients with excellence, compassion, and justice. For more information on addressing health disparities, visit the CDC’s Diabetes Program and the American Diabetes Association. Additional resources on implicit bias in healthcare can be found through the Agency for Healthcare Research and Quality.